How to Scale Peptide Manufacturing Without Running Into Pitfalls
Peptide therapeutics have surged as vital treatments for conditions like diabetes, obesity, cancer, and metabolic disorders. This growth, with over 200 peptides in clinical trials today, and the rise of GLP‑1 drugs have created unprecedented demand for peptide APIs. In response, biopharmas and CDMOs alike are investing heavily in new facilities and equipment such as … Read more